Management of Lung Manifestations in Idiopathic Inflammatory Myopathies
Rheum Dis Clin North Am. 2025 Nov;51(4):623-641. doi: 10.1016/j.rdc.2025.07.007. Epub 2025 Sep 23. ABSTRACT Pulmonary complications are a major source […]
Rheum Dis Clin North Am. 2025 Nov;51(4):623-641. doi: 10.1016/j.rdc.2025.07.007. Epub 2025 Sep 23. ABSTRACT Pulmonary complications are a major source […]
Rheum Dis Clin North Am. 2025 Nov;51(4):643-654. doi: 10.1016/j.rdc.2025.07.008. Epub 2025 Sep 9. ABSTRACT Idiopathic inflammatory myopathies (IIM) impact patients’
Annu Rev Pathol. 2025 Oct 29. doi: 10.1146/annurev-pathmechdis-080624-105114. Online ahead of print. ABSTRACT Fibroblasts have been canonically considered as extracellular
JCO Clin Cancer Inform. 2025 Oct;9:e2400259. doi: 10.1200/CCI-24-00259. Epub 2025 Oct 29. ABSTRACT PURPOSE: Flow cytometry is a key diagnostic
Rheumatology (Oxford). 2025 Oct 29:keaf575. doi: 10.1093/rheumatology/keaf575. Online ahead of print. ABSTRACT OBJECTIVES: Still’s disease (SD) is an autoinflammatory disease
Immunol Med. 2025 Oct 29:1-9. doi: 10.1080/25785826.2025.2576289. Online ahead of print. ABSTRACT Sarcoidosis is a multi-systemic granulomatous disease of unknown
Rheumatology (Oxford). 2025 Oct 29:keaf564. doi: 10.1093/rheumatology/keaf564. Online ahead of print. ABSTRACT OBJECTIVES: This study aimed to assess the risk
Rheumatology (Oxford). 2025 Oct 29:keaf527. doi: 10.1093/rheumatology/keaf527. Online ahead of print. NO ABSTRACT PMID:41160484 | DOI:10.1093/rheumatology/keaf527
Lupus Sci Med. 2025 Oct 9;12(2):e001703. doi: 10.1136/lupus-2025-001703. ABSTRACT OBJECTIVE: Antiphospholipid syndrome (APS) is a rare autoimmune condition characterised by
Rheumatology (Oxford). 2025 Oct 29:keaf566. doi: 10.1093/rheumatology/keaf566. Online ahead of print. ABSTRACT OBJECTIVE: Interstitial lung disease (ILD) is a frequent
Spine Deform. 2025 Oct 29. doi: 10.1007/s43390-025-01211-y. Online ahead of print. ABSTRACT PURPOSE: Non-depolarizing neuromuscular blocking agents (nNMBAs) have been
Clin Rheumatol. 2025 Oct 29. doi: 10.1007/s10067-025-07700-9. Online ahead of print. ABSTRACT INTRODUCTION: Treatment persistence is a surrogate marker for
Int Ophthalmol. 2025 Oct 29;45(1):453. doi: 10.1007/s10792-025-03832-8. ABSTRACT PURPOSE: To evaluate choroidal thickness (CT) and choroidal vascularity index (CVI) in
Clin Case Rep. 2025 Oct 26;13(11):e71008. doi: 10.1002/ccr3.71008. eCollection 2025 Nov. ABSTRACT The novelty of coronavirus disease 2019 (COVID-19) vaccines
Biomed Rep. 2025 Oct 2;23(6):187. doi: 10.3892/br.2025.2065. eCollection 2025 Dec. ABSTRACT Rheumatoid arthritis (RA)-associated interstitial lung disease (RA-ILD) is a
ACR Open Rheumatol. 2025 Nov;7(11):e70107. doi: 10.1002/acr2.70107. ABSTRACT OBJECTIVE: To identify predictors of reduced risk for neuropathic pain (NP) one
Arch Iran Med. 2025 Aug 1;28(8):443-451. doi: 10.34172/aim.34506. Epub 2025 Aug 1. ABSTRACT BACKGROUND: Chronic low-grade inflammation is implicated in
Rheumatology (Oxford). 2025 Oct 24:keaf538. doi: 10.1093/rheumatology/keaf538. Online ahead of print. ABSTRACT OBJECTIVES: To assess the progression of the interstitial
Viruses. 2025 Oct 21;17(10):1400. doi: 10.3390/v17101400. ABSTRACT The SARS-CoV-2 pandemic presents a broad clinical spectrum from asymptomatic cases to severe
Rheumatology (Oxford). 2025 Oct 24:keaf539. doi: 10.1093/rheumatology/keaf539. Online ahead of print. ABSTRACT Anti-neutrophil cytoplasmic antibody- (ANCA-) associated vasculitis (AAV) is
Curr Opin Allergy Clin Immunol. 2025 Dec 1;25(6):478-487. doi: 10.1097/ACI.0000000000001114. Epub 2025 Oct 10. ABSTRACT PURPOSE OF REVIEW: Omalizumab was
Rheumatology (Oxford). 2025 Oct 22:keaf552. doi: 10.1093/rheumatology/keaf552. Online ahead of print. ABSTRACT OBJECTIVES: We evaluated the efficacy of Janus kinase
Curr Opin Allergy Clin Immunol. 2025 Dec 1;25(6):488-492. doi: 10.1097/ACI.0000000000001112. Epub 2025 Oct 1. ABSTRACT PURPOSE OF REVIEW: Clinical data
Jpn J Clin Oncol. 2025 Oct 29:hyaf160. doi: 10.1093/jjco/hyaf160. Online ahead of print. ABSTRACT BACKGROUND: EMPOWER-Lung 1 and EMPOWER-Lung 3
Acta Biochim Biophys Sin (Shanghai). 2025 Oct 29. doi: 10.3724/abbs.2025169. Online ahead of print. ABSTRACT AXL, a member of the
Cytotherapy. 2025 Oct 4:S1465-3249(25)00848-5. doi: 10.1016/j.jcyt.2025.09.011. Online ahead of print. ABSTRACT BACKGROUND: The advent of novel therapeutic agents has improved
Open Access Rheumatol. 2025 Oct 22;17:221-232. doi: 10.2147/OARRR.S540008. eCollection 2025. ABSTRACT PURPOSE: To seek recommendations from a panel of experts